Summary of Notifiable Infectious Diseases and Conditions - United States, 2015
- PMID: 28796757
- DOI: 10.15585/mmwr.mm6453a1
Summary of Notifiable Infectious Diseases and Conditions - United States, 2015
Abstract
The Summary of Notifiable Infectious Diseases and Conditions - United States, 2015 (hereafter referred to as the summary) contains the official statistics, in tabular and graphical form, for the reported occurrence of nationally notifiable infectious diseases and conditions in the United States for 2015. Unless otherwise noted, data are final totals for 2015 reported as of June 30, 2016. These statistics are collected and compiled from reports sent by U.S. state and territories, New York City, and District of Columbia health departments to the National Notifiable Diseases Surveillance System (NNDSS), which is operated by CDC in collaboration with the Council of State and Territorial Epidemiologists (CSTE). This summary is available at https://www.cdc.gov/MMWR/MMWR_nd/index.html. This site also includes summary publications from previous years.
Similar articles
-
Summary of Notifiable Infectious Diseases and Conditions - United States, 2014.MMWR Morb Mortal Wkly Rep. 2016 Oct 14;63(54):1-152. doi: 10.15585/mmwr.mm6354a1. MMWR Morb Mortal Wkly Rep. 2016. PMID: 27736829
-
Summary of Notifiable Infectious Diseases and Conditions - United States, 2013.MMWR Morb Mortal Wkly Rep. 2015 Oct 23;62(53):1-122. doi: 10.15585/mmwr.mm6253a1. MMWR Morb Mortal Wkly Rep. 2015. PMID: 26492038
-
Summary of notifiable diseases--United States, 2010.MMWR Morb Mortal Wkly Rep. 2012 Jun 1;59(53):1-111. MMWR Morb Mortal Wkly Rep. 2012. PMID: 22647710
-
Summary of notifiable diseases, United States. 1990.MMWR Morb Mortal Wkly Rep. 1991 Oct 4;39(53):1-61. MMWR Morb Mortal Wkly Rep. 1991. PMID: 1656184 Review.
-
Council of State and Territorial Epidemiologists/CDC Surveillance Case Definition for Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection - United States.MMWR Recomm Rep. 2022 Dec 16;71(4):1-14. doi: 10.15585/mmwr.rr7104a1. MMWR Recomm Rep. 2022. PMID: 36520808 Free PMC article. Review.
Cited by
-
An intracellular nanobody targeting T4SS effector inhibits Ehrlichia infection.Proc Natl Acad Sci U S A. 2021 May 4;118(18):e2024102118. doi: 10.1073/pnas.2024102118. Proc Natl Acad Sci U S A. 2021. PMID: 33903242 Free PMC article.
-
An electronic medical record-based intervention to improve hepatitis A vaccination rates in the emergency department during a regional outbreak.BMJ Open Qual. 2022 Nov;11(4):e001876. doi: 10.1136/bmjoq-2022-001876. BMJ Open Qual. 2022. PMID: 36410781 Free PMC article.
-
Inhibition of Ehrlichia chaffeensis infection by cell-permeable macrocyclic peptides that bind type IV secretion effector Etf-1.PNAS Nexus. 2023 Jan 27;2(2):pgad017. doi: 10.1093/pnasnexus/pgad017. eCollection 2023 Feb. PNAS Nexus. 2023. PMID: 36874272 Free PMC article.
-
Morbilliform Eruptions in the Hospitalized Child.Dermatol Clin. 2022 Apr;40(2):191-202. doi: 10.1016/j.det.2021.12.006. Epub 2022 Mar 4. Dermatol Clin. 2022. PMID: 35366972 Free PMC article. Review.
-
The "Biological Weapons" of Ehrlichia chaffeensis: Novel Molecules and Mechanisms to Subjugate Host Cells.Front Cell Infect Microbiol. 2022 Jan 14;11:830180. doi: 10.3389/fcimb.2021.830180. eCollection 2021. Front Cell Infect Microbiol. 2022. PMID: 35155275 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical